Skip to main content

Find Clinical Trials

Home
Conditions
Hepatocellular Carcinoma

Clinical trial condition

Hepatocellular Carcinoma

Explore clinical trials studying Hepatocellular Carcinoma. Study availability and eligibility vary by location and protocol.

1,013 public trials 264 recruiting studies

Refine in advanced search Browse all conditions

Hepatocellular Carcinoma trial results

Active, Not Recruiting

A Prospective Cohort Study of Patients with Hepatobiliary Cancer Treated with Immune Checkpoint Inhibitors

NCT03695952

Conditions: Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +12 more
Locations: Changhoon Yoo Seoul, South Korea

View Trial Details

Active, Not Recruiting

An Organoid-on-chips Technique Based on Biopsy Samples and Its Efficacy in Predicting the Response to HAI in HCC

NCT05932836

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Liangrong Shi Changsha, Hunan, China

View Trial Details

Active, Not Recruiting

A Comparative Analysis of Ultrasound's Accuracy in Diagnosing HC Using Histopathology as Gold Standard

NCT06748755

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Medcare International Hospital Guiranwala, Punjab Province, Pakistan

View Trial Details

Active, Not Recruiting

HAIC Combined with PD-1 Inhibitor in Potentially Resectable Locally Advanced HCC

NCT03869034

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

Construction of a Recurrence Risk Prediction Model for Liver Resection Based on Drug Sensitivity of Patient-derived Hepatocellular Carcinoma Organoid

NCT06699524

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, Shanghai Municipality, China

View Trial Details

Active, Not Recruiting

Statin for Preventing Hepatocellular Carcinoma Recurrence After Curative Treatment

NCT03024684

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Ditmanson Medical Foundation Chiayi Christian Hospital Chiayi City, Taiwan

E-DA Hospital Kaohsiung City, Taiwan

Taichung Veterans General Hospital Taichung, Taiwan

Tainan Municipal Hospital Tainan, Taiwan

View Trial Details

Active, Not Recruiting

A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 with Valganciclovir (VGCV) in Subjects with Hepatocellular Carcinoma

NCT05595473

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Samsung Medical Center Seoul, South Korea

Kyungpook National University Hospital Deagu, South Korea

Seoul National University Hospital Seoul, South Korea

Severance Hospital Seoul, South Korea

View Trial Details

Active, Not Recruiting

Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer

NCT05620134

Conditions: Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumor, +86 more
Locations: Institut Jules Bordet Brussels, Belgium

UZA Edegem, Belgium

UZ Ghent Ghent, Belgium

CHU UCL Namur - site Godinne Yvoir, Belgium

View Trial Details

Active, Not Recruiting

Study of TACE Combined With Camrelizumab in the Treatment of HCC Patients

NCT04483284

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Department of Interventional Radiology, Zhongshan Hospital, Fudan University. Shanghai, Shanghai Municipality, China

View Trial Details

Active, Not Recruiting

Lenvatinib After Progression on Atezolizumab-bevacizumab in Hepatocellular Carcinoma

NCT06138769

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Asan Medical Center Seoul, South Korea

View Trial Details